Despite a growing focus on reducing aggressive therapy at the end of life and integrating palliative care sooner, the use of systemic anticancer therapy in the last weeks of patients' lives has remained relatively unchanged, a new analysis revealed.
Megan A. Mullins, PhD, MPH, who was not involved in the research, said she did not find it surprising that terminally ill patients are still receiving aggressive care. The researchers used the nationwide Flatiron Health electronic health record–derived database that incorporates information from about 280 US cancer clinics, including approximately 800 sites and more than 2 million patients. The authors identified adult patients who were diagnosed with cancer beginning in 2011 and who received treatment and died within 4 years of their diagnosis.
Because we determined to get every cancer patient 'cancer-free', so they continue treatments far beyond practical. And we don't pay attention to the adverse effects of the treatments: 'It's acceptable'. Chronic health issues resulting from cancer treatments are not acceptable.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NPRHealth - 🏆 144. / 63 Read more »
Source: Medscape - 🏆 386. / 55 Read more »
Source: sdut - 🏆 5. / 95 Read more »